![Douglas Blankenship](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Blankenship
Nessuna posizione attualmente
Profilo
Douglas L.
Blankenship currently works at Holdco Nuvo Group DG Ltd., as Chief Financial Officer from 2024.
Mr. Blankenship also formerly worked at Genentech, Inc., as Director-Global Quality, Compliance & Technical from 2006 to 2015, Roche Pharmaceuticals, Inc., as Director-Global Quality & Compliance from 2008 to 2015, Amgen Technology (Ireland) Unlimited Co., as Finance Director from 2006 to 2008, Virage Logic Corp., as Finance Director, Humacyte Global, Inc., as Chief Financial Officer, and Dova Pharmaceuticals, Inc., as CFO & Principal Accounting Officer from 2017 to 2018.
Mr. Blankenship received his undergraduate degree from California Polytechnic State University (San Luis Obispo) and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Posizioni attive di Douglas Blankenship
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Douglas Blankenship
| Società | Posizione | Fine |
|---|---|---|
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Direttore Finanziario/CFO | 19/05/2021 |
| DOVA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 31/01/2018 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Responsabile della Conformità | 01/10/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/10/2015 |
Amgen Technology (Ireland) Unlimited Co.
 Amgen Technology (Ireland) Unlimited Co. Medical/Nursing ServicesHealth Services Provides health care services | Direttore Finanziario/CFO | 01/01/2008 |
Formazione di Douglas Blankenship
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
89
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Virage Logic Corp.
 Virage Logic Corp. SemiconductorsElectronic Technology Provides embedded memory technology solutions | Electronic Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Amgen Technology (Ireland) Unlimited Co.
Amgen Technology (Ireland) Unlimited Co. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
